# Pfizer opens $68.5M gene therapy clinical manufacturing facility in Durham, North Carolina

Pfizer announced the opening of a new, state-of-the-art clinical manufacturing facility in Durham, NC, as part of an $800 million investment over six years to build three gene therapy manufacturing facilities. The Durham facility will create more than 50 new jobs and is part of Pfizer's expansion of end-to-end gene therapy capabilities.

- Type: New facility
- Announced: 2021-12-15
- Where: Durham, North Carolina, United States
- Value: $68.5M
- Jobs: 50
- Starts operating: 15 Dec 2021
- Status: completed
- Products: gene therapy clinical supplies, biologics
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Pfizer](https://endata.com/companies/892.md)

## Sources

- [pfizer.com](https://www.pfizer.com/news/press-release/press-release-detail/pfizer-invests-685-million-new-state-art-facility-durham), 2021-12-15: "Pfizer Inc. announced today the opening of a new, state-of-the-art clinical manufacturing facility in Durham, NC."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.